The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to
the Securities and Exchange Commission (SEC)
by insider Breitmeyer James B since year 2005.
The trader's CIK number is 1244823.
At the time of this reporting, Breitmeyer James B is the EVP, CMO of Cadence Pharmaceuticals Inc .
(stock ticker symbol CADX).
See this page for all insider trading activities at Cadence Pharmaceuticals Inc .
| Trade Date | Symbol | Company Name (Issuer) | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|---|
| 2011-11-03 | CADX | Cadence Pharmaceuticals Inc | Sale | 12,500 | 5.70 | 71,300 |
| 2011-11-02 | CADX | Cadence Pharmaceuticals Inc | Option Ex | 12,500 | .00 | 0 |
| 2011-07-11 | CADX | Cadence Pharmaceuticals Inc | Sale | 3,000 | 8.99 | 26,970 |
| 2011-07-11 | CADX | Cadence Pharmaceuticals Inc | Option Ex | 3,000 | 3.20 | 9,600 |
| 2011-05-02 | CADX | Cadence Pharmaceuticals Inc | Option Ex | 12,000 | 3.20 | 38,400 |
| 2011-05-02 | CADX | Cadence Pharmaceuticals Inc | Sale | 12,000 | 8.35 | 100,164 |
| 2011-04-01 | CADX | Cadence Pharmaceuticals Inc | Option Ex | 7,000 | 3.20 | 22,400 |
| 2011-04-01 | CADX | Cadence Pharmaceuticals Inc | Sale | 7,000 | 9.20 | 64,399 |
| 2011-03-04 | CADX | Cadence Pharmaceuticals Inc | Sale | 7,000 | 8.50 | 59,500 |
| 2011-03-04 | CADX | Cadence Pharmaceuticals Inc | Option Ex | 7,000 | 3.20 | 22,400 |
| 2011-02-03 | CADX | Cadence Pharmaceuticals Inc | Sale | 39,000 | 7.38 | 288,015 |
| 2011-02-03 | CADX | Cadence Pharmaceuticals Inc | Option Ex | 39,000 | 3.20 | 124,800 |
| 2010-11-02 | CADX | Cadence Pharmaceuticals Inc | Sale | 18,000 | 9.05 | 162,864 |
| 2010-11-01 | CADX | Cadence Pharmaceuticals Inc | Sale | 7,000 | 9.00 | 63,000 |
| 2010-11-02 | CADX | Cadence Pharmaceuticals Inc | Option Ex | 18,000 | 3.20 | 57,600 |
| 2010-11-01 | CADX | Cadence Pharmaceuticals Inc | Option Ex | 7,000 | 3.20 | 22,400 |
| 2010-10-05 | CADX | Cadence Pharmaceuticals Inc | Option Ex | 7,000 | 3.20 | 22,400 |
| 2010-10-05 | CADX | Cadence Pharmaceuticals Inc | Sale | 7,000 | 8.50 | 59,500 |
| 2010-09-27 | CADX | Cadence Pharmaceuticals Inc | Option Ex | 2,363 | 3.20 | 7,561 |
| 2010-09-27 | CADX | Cadence Pharmaceuticals Inc | Sale | 2,363 | 8.50 | 20,085 |
| 2010-09-29 | CADX | Cadence Pharmaceuticals Inc | Option Ex | 4,637 | 3.20 | 14,838 |
| 2010-09-29 | CADX | Cadence Pharmaceuticals Inc | Sale | 4,637 | 8.50 | 39,414 |
| 2010-04-19 | CADX | Cadence Pharmaceuticals Inc | Option Ex | 1,000 | 3.20 | 3,200 |
| 2010-04-19 | CADX | Cadence Pharmaceuticals Inc | Sale | 1,000 | 10.00 | 10,000 |
| 2010-02-01 | CADX | Cadence Pharmaceuticals Inc | Sale | 1,000 | 10.00 | 10,000 |
| 2010-02-01 | CADX | Cadence Pharmaceuticals Inc | Option Ex | 1,000 | 3.20 | 3,200 |
| 2010-01-05 | CADX | Cadence Pharmaceuticals Inc | Option Ex | 1,000 | 3.20 | 3,200 |
| 2010-01-05 | CADX | Cadence Pharmaceuticals Inc | Sale | 1,000 | 10.00 | 10,000 |
| 2009-12-17 | CADX | Cadence Pharmaceuticals Inc | Sale | 1,000 | 10.00 | 10,000 |
| 2009-12-17 | CADX | Cadence Pharmaceuticals Inc | Option Ex | 1,000 | 3.20 | 3,200 |
| 2009-11-05 | CADX | Cadence Pharmaceuticals Inc | Option Ex | 1,000 | 3.20 | 3,200 |
| 2009-11-05 | CADX | Cadence Pharmaceuticals Inc | Sale | 1,000 | 10.00 | 10,000 |
| 2009-10-01 | CADX | Cadence Pharmaceuticals Inc | Option Ex | 1,000 | 3.20 | 3,200 |
| 2009-10-01 | CADX | Cadence Pharmaceuticals Inc | Sale | 1,000 | 10.96 | 10,960 |
| 2009-09-01 | CADX | Cadence Pharmaceuticals Inc | Option Ex | 1,000 | 3.20 | 3,200 |
| 2009-09-01 | CADX | Cadence Pharmaceuticals Inc | Sale | 1,000 | 10.81 | 10,810 |
| 2009-08-03 | CADX | Cadence Pharmaceuticals Inc | Option Ex | 1,000 | 3.20 | 3,200 |
| 2009-08-03 | CADX | Cadence Pharmaceuticals Inc | Sale | 1,000 | 12.11 | 12,110 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Breitmeyer James B (EVP, CMO of Cadence Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.